Ampligen for Pancreatic Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to assess the safety and efficacy of Ampligen in patients with locally advanced pancreatic adenocarcinoma
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, it does mention that you should not have received investigational drugs within 6 weeks before starting the study medication.
Is Ampligen (Rintatolimod) safe for use in humans?
How does the drug Ampligen differ from other treatments for pancreatic cancer?
Ampligen (rintatolimod) is unique because it works by boosting the immune system through the TLR-3 receptor, potentially improving survival in pancreatic cancer patients. Unlike standard chemotherapy, it enhances the body's immune response, particularly increasing B-cell numbers, which may contribute to longer survival.12567
What data supports the effectiveness of the drug Rintatolimod (Ampligen) for pancreatic cancer?
Who Is on the Research Team?
David R Strayer, MD
Principal Investigator
AIM ImmunoTech Inc.
Are You a Good Fit for This Trial?
This trial is for adults with locally advanced pancreatic adenocarcinoma who've completed at least 4 months of FOLFIRINOX treatment without disease progression. Participants must have a life expectancy of over 3 months, weigh at least 40kg, and have a Karnofsky Performance Status of 80 or higher. They should not be pregnant or breastfeeding and must agree to use contraception during the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Ampligen in combination with SOC or SOC alone until disease progression
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Rintatolimod
Find a Clinic Near You
Who Is Running the Clinical Trial?
AIM ImmunoTech Inc.
Lead Sponsor
Amarex Clinical Research
Collaborator